Xiao-wei Nie
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
PUS7-Mediated Pseudouridylation of TGFBI Drives Vascular Remodeling in Pulmonary Hypertension.
Journal: Circulation
Published: September 01, 2026
Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation.
Journal: Frontiers in pharmacology
Published: October 25, 2024
Pharmacology of Hydrogen Sulfide and Its Donors in Cardiometabolic Diseases.
Journal: Pharmacological reviews
Published: December 18, 2023
Targeting NKAα1 to treat Parkinson's disease through inhibition of mitophagy-dependent ferroptosis.
Journal: Free radical biology & medicine
Published: December 08, 2023
Efficient Creation of Ultracold Ground State ^{6}Li^{40}K Polar Molecules.
Journal: Physical review letters
Published: October 05, 2023
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice.
Journal: Metabolism: clinical and experimental
Published: February 03, 2023
Targeting the Na+/K+ ATPase DR-region with DR-Ab improves doxorubicin-induced cardiotoxicity.
Journal: Free radical biology & medicine
Published: January 26, 2023
Polysulfide Protects Against Diabetic Cardiomyopathy Through Sulfhydration of Peroxisome Proliferator-Activated Receptor-γ and Sirtuin 3.
Journal: Antioxidants & redox signaling
Published: November 02, 2022
Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions.
Journal: Antioxidants & redox signaling
Published: October 31, 2022
The cannabis paradox: contrasting role for marijuana in cardiovascular disease.
Journal: Signal transduction and targeted therapy
Published: June 13, 2022
Last Updated: 09/26/2026